Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007.
D000964:Antimetabolites, Antineoplastic / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000069287:Capecitabine; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D007118:Immunoassay; D008495:Medical Oncology / Q000193:education* / Q000639:trends; D009369:Neoplasms / Q000188:drug therapy*; D010597:Pharmacogenetics / Q000193:education* / Q000639:trends
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil